Correlation Between STADION TRILOGY and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both STADION TRILOGY and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining STADION TRILOGY and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between STADION TRILOGY ALTERNATIVE and Pfizer Inc, you can compare the effects of market volatilities on STADION TRILOGY and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in STADION TRILOGY with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of STADION TRILOGY and Pfizer.

Diversification Opportunities for STADION TRILOGY and Pfizer

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between STADION and Pfizer is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding STADION TRILOGY ALTERNATIVE and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and STADION TRILOGY is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on STADION TRILOGY ALTERNATIVE are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of STADION TRILOGY i.e., STADION TRILOGY and Pfizer go up and down completely randomly.

Pair Corralation between STADION TRILOGY and Pfizer

Assuming the 90 days horizon STADION TRILOGY ALTERNATIVE is expected to under-perform the Pfizer. But the mutual fund apears to be less risky and, when comparing its historical volatility, STADION TRILOGY ALTERNATIVE is 4.78 times less risky than Pfizer. The mutual fund trades about -0.04 of its potential returns per unit of risk. The Pfizer Inc is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  3,425  in Pfizer Inc on September 6, 2022 and sell it today you would earn a total of  1,666  from holding Pfizer Inc or generate 48.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

STADION TRILOGY ALTERNATIVE  vs.  Pfizer Inc

 Performance (%) 
       Timeline  
STADION TRILOGY ALTE 
STADION Performance
0 of 100
Over the last 90 days STADION TRILOGY ALTERNATIVE has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong fundamental indicators, STADION TRILOGY is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

STADION Price Channel

Pfizer Inc 
Pfizer Performance
9 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical and fundamental indicators, Pfizer may actually be approaching a critical reversion point that can send shares even higher in January 2023.

Pfizer Price Channel

STADION TRILOGY and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with STADION TRILOGY and Pfizer

The main advantage of trading using opposite STADION TRILOGY and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if STADION TRILOGY position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
STADION TRILOGY vs. Home Depot
STADION TRILOGY vs. GROWTH FUND OF
STADION TRILOGY vs. VANGUARD SMALL-CAP GROWTH
The idea behind STADION TRILOGY ALTERNATIVE and Pfizer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Pfizer vs. Arbutus Biopharma Corp
Pfizer vs. ACADIA Pharmaceuticals
Pfizer vs. AbbVie Inc
Pfizer vs. Abeona Therapeutics
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go